What does BIOTECH-SANCE do?

BIOTECH-SANCE is a healthcare practice in Esneux. Private Limited, started on 22 October 2010, 1 establishment.

What is the address of BIOTECH-SANCE?

The registered office of BIOTECH-SANCE is located at Rue de Mery 42, 4130 Esneux.

Is BIOTECH-SANCE still active?

Not as usual. The CBE lists BIOTECH-SANCE with legal situation “Vrijwillige ontbinding – vereffening”.

Is BIOTECH-SANCE registered on Peppol?

No, BIOTECH-SANCE is currently not registered on the Peppol network.

What is the enterprise number of BIOTECH-SANCE?

The enterprise number of BIOTECH-SANCE is BE0830539041.

When was BIOTECH-SANCE founded?

BIOTECH-SANCE was founded on 22 October 2010.

Who are the directors of BIOTECH-SANCE?

According to the 2025 annual accounts, the directors of BIOTECH-SANCE are: Olivier ESCHWEILER.

Is BIOTECH-SANCE a reliable company?

Databakkes does not pass judgement; this is what the sources say: Vrijwillige ontbinding – vereffening according to the CBE, started on 22 October 2010; 6 annual accounts filed, latest fiscal year 2025; 1 directors known from the annual account.

How much profit did BIOTECH-SANCE make in 2025?

BIOTECH-SANCE recorded a loss after taxes of € 782 in financial year 2025.

BIOTECH-SANCE (Private Limited) - Esneux - BE0830539041

Dossier BIOTECH-SANCE, printed on 30 October 2026 from databakkes.be/en/0830539041/biotech-sance. Sources: CBE, National Bank of Belgium, Belgian Official Gazette.

Warning lights

Signals from the annual accounts, the CBE and the Official Gazette, each with its threshold and source. No score, no verdict.

Negative equity NBB

More debt than assets in 4 of the last 4 fiscal years.
Two loss years in a row NBB

Negative result in 2024 and 2025.
Legal situation KBO

Vrijwillige ontbinding – vereffening according to the CBE.

Financials

Financial year 2025

BIOTECH-SANCE from Esneux, company number BE0830539041, closed financial year 2025 with a result of € -782 after tax. Compared with financial year 2024, the result moved from € -1,693 to € -782. The company made a loss. More debts than assets. High debts against a small own buffer. The most recent annual accounts were filed with the National Bank of Belgium on December 27, 2025.

What it is worth Caution

€ -497,456

Assets minus debts, by the books. What is left if everything were sold and paid today.

Loss Caution

€ -782

▲ 54 % less loss than in 2024

Profit after tax over the fiscal year.

Cash in the bank

€ 31,664

Cash and bank balances on the last day of the fiscal year.

Where the profit goes Caution

Loss, nothing to pay out

Reserves fell to € -516,056.

People and assets in 2025

Full-time equivalents estimate The annual accounts report no full-time equivalents. A micro company with one active director is usually run by that person; this is an assumption, not a figure from the source.

≈ 1

No payroll staff. One director, so that person most likely runs the business.

Debts at end 2025

Bank debt

None

No bank loans on the last day of the fiscal year.

Owed to suppliers

€ 402

Supplier invoices still open on the last day of the fiscal year.

Key figures per fiscal year Download key figures (CSV)
	2022	2023	2024	2025	Change 2024 → 2025
Profit after taxes	€ -2,464 Profit after taxes 2022: € -2,464 First fiscal year in the series	€ -1,920 Profit after taxes 2023: € -1,920 ▲ € 544 vs 2022 (€ -2,464) Favourable step	€ -1,693 Profit after taxes 2024: € -1,693 ▲ € 226 vs 2023 (€ -1,920) Favourable step	€ -782 Profit after taxes 2025: € -782 ▲ € 911 vs 2024 (€ -1,693) Favourable step	▲ € 911
Equity	€ -493,061 Equity 2022: € -493,061 First fiscal year in the series	€ -494,981 Equity 2023: € -494,981 Unchanged (€ -493,061) Unfavourable step	€ -496,674 Equity 2024: € -496,674 Unchanged (€ -494,981) Unfavourable step	€ -497,456 Equity 2025: € -497,456 Unchanged (€ -496,674) Unfavourable step
Total debts	€ 402 Total debts 2022: € 402 First fiscal year in the series	€ 402 Total debts 2023: € 402 Unchanged (€ 402) Unchanged	€ 402 Total debts 2024: € 402 Unchanged (€ 402) Unchanged	€ 402 Total debts 2025: € 402 Unchanged (€ 402) Unchanged
Cash	€ 31,507 Cash 2022: € 31,507 First fiscal year in the series	€ 31,507 Cash 2023: € 31,507 Unchanged (€ 31,507) Unchanged	€ 31,554 Cash 2024: € 31,554 Unchanged (€ 31,507) Favourable step	€ 31,664 Cash 2025: € 31,664 Unchanged (€ 31,554) Favourable step
Retained profit	€ -511,661 Retained profit 2022: € -511,661 First fiscal year in the series	€ -513,581 Retained profit 2023: € -513,581 Unchanged (€ -511,661) Unfavourable step	€ -515,274 Retained profit 2024: € -515,274 Unchanged (€ -513,581) Unfavourable step	€ -516,056 Retained profit 2025: € -516,056 Unchanged (€ -515,274) Unfavourable step
Balance sheet total	€ 38,061 Balance sheet total 2022: € 38,061 First fiscal year in the series	€ 36,142 Balance sheet total 2023: € 36,142 ▼ 5% vs 2022 (€ 38,061) Unchanged	€ 34,449 Balance sheet total 2024: € 34,449 ▼ 5% vs 2023 (€ 36,142) Unchanged	€ 33,666 Balance sheet total 2025: € 33,666 ▼ 2% vs 2024 (€ 34,449) Unchanged	▼ 2%

Key figures of BIOTECH-SANCE, fiscal years 2022 to 2025, from the annual accounts filed with the National Bank of Belgium.Next annual account (fiscal year 2026) expected before 31 October 2026.

What happened to BIOTECH-SANCE?

What happened at BIOTECH-SANCE in recent years, according to the Belgian Official Gazette, the CBE and the National Bank:

BIOTECH-SANCE is active according to the CBE. Legal situation: Vrijwillige ontbinding – vereffening.

Dec 27, 2025 New annual accounts for financial year 2025: loss of € 782. filed late Source: NBB ↗
2020 Olivier ESCHWEILER became a director. NBB
Oct 22, 2010 New establishment in Jemeppe-sur-Sambre. KBO
Oct 22, 2010 Start of the company according to the CBE. KBO

In short

From € 2,464 loss in 2022 to € 782 loss in 2025.

Paid € 47 in corporate taxes since 2022.

Original PDFs at the National Bank ↗

Management

Olivier ESCHWEILER

BIOTECH-SANCE

SOCIÉTÉ DE BUREAUX D'ÉTUDES PLURIDISCIPLINAIRES

Cabinet d'avocats Olivier Eschweiler

IMMO D.A.B.

Behind BIOTECH-SANCE is Olivier ESCHWEILER. Olivier ESCHWEILER is also behind SOCIÉTÉ DE BUREAUX D'ÉTUDES PLURIDISCIPLINAIRES, Cabinet d'avocats Olivier Eschweiler, IMMO D.A.B. and BOBBIONI-MASTRATISI.

Directors

According to the 2025 annual accounts

Olivier ESCHWEILER

Liquidator

Also active at: SOCIÉTÉ DE BUREAUX D'ÉTUDES PLURIDISCIPLINAIRES, Cabinet d'avocats Olivier Eschweiler, IMMO D.A.B., BOBBIONI-MASTRATISI

since 2020

Establishments

Establishment units

Physical locations of this company

Registered office

Rue de Mery 42

4130 Esneux

2.234.644.725

Rue de Floreffe,Spy 69

5190 Jemeppe-sur-Sambre

Active since 22 October 2010

Who else lives here?

A building full of entrepreneurs or one very busy letterbox? Another 6 companies are registered at this address.

All companies at this address →

SOCIÉTÉ DE BUREAUX D'ÉTUDES PLURIDISCIPLINAIRES same network

€ 4,523 gross margin · 2025

ROGIVA

EP LAW

€ 168,556 gross margin · 2025

PERFECT SERVICES

€ -445 gross margin · 2024

Cabinet d'avocats Olivier Eschweiler same network

€ 195,967 gross margin · 2025

+1 more

What is an establishment unit? An establishment unit is a geographically identifiable place where activities of the enterprise are carried out.

Details

Company number

0830.539.041

VAT number

BE 0830.539.041

Registered office

Rue de Mery 42, 4130 Esneux

Names & denominations

BIOTECH-SANCE

Enterprise type

Rechtspersoon

Legal form

Private limited company

Legal situation

Vrijwillige ontbinding – vereffening

Start date

22 October 2010

Peppol

Not registered

Activities · NACE

Activiteiten op het gebied van voeding

Overige menselijke gezondheidszorg, n.e.g.

Verhuur en lease van medisch en paramedisch materieel

View on CBE Public ↗ Annual accounts (NBB) ↗

BIOTECH-SANCE

Warning lights

Financials

What happened to BIOTECH-SANCE?

Management

Directors

Establishments

Establishment units

Who else lives here?

Details

Frequently asked questions